Hikono Hirokazu, Mase Masaji, Matsuu Aya, Nakayama Megumi, Saito Takehiko
National Institute of Animal Health, National Agriculture and Food Research Organization, 3-1-5 Kannondai, Tsukuba, Ibaraki 305-0854, Japan.
Vet Immunol Immunopathol. 2013 Jan 15;151(1-2):83-9. doi: 10.1016/j.vetimm.2012.10.005. Epub 2012 Nov 2.
Because it is expected to induce cross-reactive serum and mucosal antibody responses, mucosal vaccination against highly pathogenic avian influenza (HPAI) is potentially superior to conventional parenteral vaccination. Here, we tested whether intraocular vaccination with an inactivated AI virus induced protective antibody responses in chickens. Chickens were inoculated intraocularly twice with 10(4) hemagglutination units of an inactivated H5N1 HPAI virus. Four weeks after the second vaccination, the chickens were challenged with a lethal dose of the homologous H5N1 HPAI virus. Results showed that most of the vaccinated chickens mounted positive antibody responses. The median serum hemagglutination inhibition titer was 1:80. Addition of CpG oligodeoxynucleotide 2006 or cholera toxin to the vaccine did not enhance serum antibody titers. Cross-reactive anti-hemagglutinin IgG, but not IgA, was detected in oropharyngeal secretions. In accordance with these antibody results, most vaccinated chickens survived a lethal challenge with the H5N1 HPAI virus and did not shed the challenge virus in respiratory or digestive tract secretions. Our results show that intraocular vaccination with an inactivated AI virus induces not only systemic but also mucosal antibody responses and confers protection against HPAI in chickens.
由于黏膜疫苗接种有望诱导交叉反应性血清和黏膜抗体反应,因此针对高致病性禽流感(HPAI)的黏膜疫苗接种可能优于传统的肠胃外疫苗接种。在此,我们测试了用灭活的禽流感病毒进行眼内疫苗接种是否能在鸡体内诱导保护性抗体反应。给鸡眼内接种两次10⁴血凝素单位的灭活H5N1高致病性禽流感病毒。第二次接种四周后,用致死剂量的同源H5N1高致病性禽流感病毒对鸡进行攻毒。结果显示,大多数接种疫苗的鸡产生了阳性抗体反应。血清血凝抑制效价中位数为1:80。向疫苗中添加CpG寡脱氧核苷酸2006或霍乱毒素并未提高血清抗体效价。在口咽分泌物中检测到了交叉反应性抗血凝素IgG,但未检测到IgA。根据这些抗体结果,大多数接种疫苗的鸡在受到H5N1高致病性禽流感病毒致死性攻毒后存活下来,并且在呼吸道或消化道分泌物中未排出攻毒病毒。我们的结果表明,用灭活的禽流感病毒进行眼内疫苗接种不仅能诱导全身性抗体反应,还能诱导黏膜抗体反应,并能使鸡对高致病性禽流感产生保护作用。